Ferroptosis: molecular mechanisms and health implications

  • Cell Res. 2021 Feb;31(2):107-125. doi: 10.1038/s41422-020-00441-1.
Daolin Tang  1  2 Xin Chen  3  4 Rui Kang  4 Guido Kroemer  5  6  7  8  9
Affiliations
  • 1. Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation; The Third Affiliated Hospital; Guangzhou Medical University, Guangzhou, Guangdong, 511436, China. [email protected].
  • 2. Department of Surgery, UT Southwestern Medical Center, Dallas, TX, 75390, USA. [email protected].
  • 3. Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation; The Third Affiliated Hospital; Guangzhou Medical University, Guangzhou, Guangdong, 511436, China.
  • 4. Department of Surgery, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
  • 5. Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France. [email protected].
  • 6. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, 94800, France. [email protected].
  • 7. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, 75015, France. [email protected].
  • 8. Suzhou Institute for Systems Biology, Chinese Academy of Sciences, Suzhou, Jiangsu, China. [email protected].
  • 9. Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, 17176, Sweden. [email protected].
Abstract

Cell death can be executed through different subroutines. Since the description of Ferroptosis as an iron-dependent form of non-apoptotic cell death in 2012, there has been mounting interest in the process and function of Ferroptosis. Ferroptosis can occur through two major pathways, the extrinsic or transporter-dependent pathway and the intrinsic or enzyme-regulated pathway. Ferroptosis is caused by a redox imbalance between the production of oxidants and Antioxidants, which is driven by the abnormal expression and activity of multiple redox-active Enzymes that produce or detoxify free radicals and lipid oxidation products. Accordingly, Ferroptosis is precisely regulated at multiple levels, including epigenetic, transcriptional, posttranscriptional and posttranslational layers. The transcription factor NFE2L2 plays a central role in upregulating anti-ferroptotic defense, whereas selective Autophagy may promote ferroptotic death. Here, we review current knowledge on the integrated molecular machinery of Ferroptosis and describe how dysregulated Ferroptosis is involved in Cancer, neurodegeneration, tissue injury, inflammation, and Infection.